Effectiveness of a mindfulness-based cognitive therapy program as an adjunct to pharmacotherapy in patients with panic disorder.

Study at a glance

Characteristics	Clinical trial Peer reviewed
Population	Patients with panic disorder
Interventions	Mindfulness-based cognitive therapy Pharmacotherapy
Topics	Anxiety Meditation
Key findings	The abstract indicates that a mindfulness-based cognitive therapy program as an adjunct to pharmacotherapy is effective for patients with panic disorder, but provides no specific outcomes or effect sizes.

Other non-randomized and open-label trials on anxiety, most cited first.

Study	Year	Design	Participants
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression	2018	Clinical trial	n = 20
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder Subjects with obsessive-compulsive disorder (OCD)	2006	Controlled clinical trial
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder	2010	Open-label trial	n = 33
Emotions and brain function are altered up to one month after a single high dose of psilocybin. Healthy volunteers (7 female, 5 male)	2020	Open-label pilot study	n = 12
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study Older long-term AIDS survivor (OLTAS) self-identified gay men with moderate-to-severe...	2020	Open-label study